WAKE UP TO A BETTER PHYSIQUE
Magnum G-SPRING ®Burn fat and build lean muscle while you sleep? It’s not a dream.
Magnum G-Spring helps you lose fat, grow muscle and recover – all while you enjoy a deep, restful, sleep.
Magnum G-Spring is a multi-ingredient Pharmaceutical Grade formulation that effectively increases resting GH levels while you sleep. This increase in GH allows you to wake up feeling more rested, energized, focused and – best of all –leaner and more muscular.
Now you can train harder, recover better, burn fat more efficiently, and, at the end of the day, fall into a deep sleep for improved recovery.
Magnum G-Spring – BUILD WHILE YOU SLEEP
INGREDIENTS IN MAGNUM G-SPRING ® WILL IMPROVE:
A GREAT PHARMACEUTICAL GRADE NATURAL GH ENHANCING PRODUCT WILL PRODUCE THE FOLLOWING RESULTS:
MAGNUM G-SPRING ® IS THE BEST CHOICE FOR YOUR PHARMACEUTICAL GRADE NATURAL GH ENHANCING PRODUCT BECAUSE:
Magnum G-SPRING ® features the ultra-effective ingredient Puerarin (98%). Puerarin is an isoflavone found in varying potencies in plants such as Kudzu, but standardized for effectiveness in Magnum G-SPRING ®. Isoflavones often act as phytoestrogens, influencing sex hormones and protein synthesis in humans. Studies show Puerarin can help improve insulin function and block estrogen, both of which create a more anabolic environment in your body. Puerarin does this by stimulating the GHRH receptor to increase GH release. The GHRH pathway is an effective secondary pathway for GH release and the use of Puerarin has a huge effect on increasing circulating GH. Puerarin has also been shown to be an effective anti-aromatase and a natural SERM. Puerarin has also been shown to stimulate phosphoinositol 3 kinase (PI3K), which is the same anabolic pathway stimulated by IGF-1 and Insulin to drive glycogen into your muscles.
A study published in the Hormone and Metabolic Research Journal showed that Puerarin significantly increased GHRH (growth hormone releasing hormone). The researchers suggested that the Puerarin acted either on GH secretagogue receptors or on the GHRH receptor of somatotrophin as possible agonists or an inhibitor on somatostatin receptor to release GH, respectively.